维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Brate A"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	qlae microtubule stabihzing agent latdimalide does not bind in the taxoid site,kills cells resistant to paclitaxel and epothilones, and ma ynot require its epoxide moiety for activity显示文摘	Pryor DE O' Brate A Bilcer G	2002	Biochemistry2002，41，29：	1
2	Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol显示文摘	Zhou J O'brate A Zelnak A	2004	Cancer Res2004，64，23：	1
3	Predictive molecular markers in non-small cell lung cancer 显示文摘	Rosell R Taren M O'Brate A	2001	Curr Opin Oncol2001，13，2：	1
4	Microtubule disruption targets HIF-1alpha mRNA to cytoplasmic P-bodies for translational repression显示文摘	Carbonaro M O'Brate A Giannakakou P	2011	J Cell Biol2011，192，1：	1
5	Predictive molecular markers in non-small-cell lung cancer显示文摘	Rosell R Taron M O' Brate A	2001	Curt Opin Oncol2001，13，2：	1
6	Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol 显示文摘	Zhou J O'brate A Zelnak A	2004	Cancer Res2004，279，15：	1
7	Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol显示文摘	Zhou J O′brate A Zelnak A	2004	Cancer Res2004，64，23：	1
8	Translational oncogenomics:toward rational therapeutic decision-making 显示文摘	Rosell R Monzo M O Brate A	2002	Curr Opin Oncol2002，14，2：	1
9	The synergistic eombination of the famesyl transferase inhibitor lonafarnib and paclitaxel enhances tu- bulin acetylation and requires a functional tubulin deacetylase 显示文摘	Marcus AI Zhou J O' Brate A	2005	Cancer Res2005，65，9：	1
10	The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclita xel enhances tubulin acetylation and requires a functional tubulin deacetylase显示文摘	MARCUS A I ZHOU J O′BRATE A	2005	Cancer Res2005，65，9：	1
11	The importance of p53 location:nuclear or cytoplasmic zip code?显示文摘	O'BRATE A GIANNAKAKOU P	2003	Drug Resist Updat2003，6，6：	1
12	Predictive molecular markers in nonsmall cell lung cancer显示文摘	Rosell R Taron M O'Brate A	2008	Curr Opin Oncol2008，2，10：	1
13	The importance of p53 location: nuclear or cytoplasmic zip code显示文摘	O'Brate A Giannakakou P	2003	Drug Resist Updat2003，6，6：	1
14	Translational oncogenomics:toward rational therapeutic decision-making显示文摘	Rosell R Monzo M O'Brate A	2002	Curr Opin Oncol2002，14，：	1
15	Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol显示文摘	Zhou J O'brate A Zelnak A	2004	Cancer Res2004，64，23：	1
16	Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol显示文摘	Zhou J O' brate A Zelnak A	2004	Cancer Res2004，64，：	1
17	Translational oncogenomics:toward rational therapeutic decision making显示文摘	Rosell R Monzo M O'Brate A	2002	Curr Opin Oncol2002，14，2：	1
18	The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity显示文摘	Pryor DE O'Brate A Bilcer G	2002	Biochemistry2002，41，29：	1
19	Predictive molecular markers in non-small cell lung cancer显示文摘	Rosen R Tarón M O'Brate A	2001	Curt Opin Oncol2001，13，2：	1
20	Pharmacogenomic research and serum DNA analysis in the treatment of non-small-cell lung cancer显示文摘	Rosell R O' Brate A Monzo M et at	2001	Rev Oncol2001，38，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示